5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)

NCT04610372 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

168

Enrollment

OTHER

Sponsor class

Conditions

Oligometastatic Prostate Cancer

Interventions

RADIATION: Hypofractionated external beam radiotherapy
RADIATION: High dose rate brachytherapy
RADIATION: Permanent seed implant
RADIATION: Stereotactic body radiotherapy

Sponsor

British Columbia Cancer Agency